Subsequent observations that BTK overexpression by B cells can manifest in generalized autoimmunity in mice [11, 29] and that circulating B cells of patients with rheumatoid arthritis and Sjogren’s disease over-express BTK [12], suggested that BTK inhibition may have therapeutic potential in human autoimmune diseases. This evidence concerns the gene BTK and Autoimmunity.